Abstract:In cancer clinics, an in vivo form of the senescence-associated secretory phenotype (SASP) is driven by a DNA damage secretory program (DDSP) provoked by side effects of genotoxic therapeutics including chemotherapy and radiation which fuel advanced pathologies particularly cancer resistance. However, the complete mechanism underlying DDSP development in the tumor microenvironment (TME) remains unclear. Here we report that genotoxic agents frequently used in clinical oncology induce a gene expression pattern distinct from the one that is shaped by non-genotoxic drugs. Specifically, the zinc finger and scan domain containing 4 (Zscan4) is upregulated upon DNA damage in stromal cells and engaged in DNA damage response (DDR) in genotoxic settings. Apart from the established functions in telomere elongation and genomic integrity of stem cells, Zscan4 is central for the Rap1/TRF2 assembly and orchestrates the long term DDR signaling in differentiated stromal cells. In response to DNA damage, the mammalian target of rapamycin (mTOR) is phosphorylated in the cytoplasm of stromal cells and relays DDR signals, a phenomenon different from human cancer cells. There are physical interactions between the mTOR and the IKK complexes, events functionally implicating the NF-κB machinery that is regulated by both the IL-1α/IRAK1 and mTOR/Raptor axes. We determined that mTORC1 is a critical mediator of DDSP programmatic implementation by conducting signals from upstream molecules including p38 and PI3K/Akt, molecules activated in DNA damage events. We revealed that the ligand IL-1α signals through IL-1R and TAK1, the latter a member of the mitogen-activated kinase kinase kinase (MAPKKK) family that induces a proinflammatory cascade by activating JNK/p38 and NF-κB. Further, targeting p38, mTOR or TAK1 with small molecule inhibitors in vivo significantly abrogated cancer resistance acquired from the TME in chemotherapeutic cycles. Overall, our study substantiates p38, mTOR and TAK1 as a group of new candidates for future TME-oriented intervention to minimize resistance provoked by anticancer regimes, and suggests that anti-p38/mTOR/TAK1 agents may be repurposed to sensitize tumors by effectively targeting the TME. Our data disclose a novel mechanism of SASP (or DDSP) signaling in classical therapeutic settings, thus opening new avenues to improve clinical outcomes in the current era of precision medicine. Citation Format: Yu Sun, Boyi Zhang, Fei Chen, Paul Chiao. A persistently activated signaling network regulates the DNA damage secretory program to promote cancer resistance driven by the therapeutically damaged tumor microenvironment. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr LB-234.

Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction

HR Repair Pathway Plays a Crucial Role in Maintaining Neural Stem Cell Fate under Irradiation Stress.

Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response

SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells.

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

ZNF506-dependent positive feedback loop regulates H2AX signaling after DNA damage

Regulation of SIRT1 activity by genotoxic stress.

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

DSB-induced oxidative stress: Uncovering crosstalk between DNA damage response and cellular metabolism

The unfolded protein response of the endoplasmic reticulum protects Caenorhabditis elegans against DNA damage caused by stalled replication forks

EXO1-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells

Damage and Replication Stress Responses

Dysregulation of DAF-16/FOXO3A-mediated stress responses accelerates oxidative DNA damage induced aging

DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks.

Base excision repair accessory factors in senescence avoidance and resistance to treatments

EXO1 and DNA2-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells

A Persistently Activated Signaling Network Regulates The Dna Damage Secretory Program To Promote Cancer Resistance Driven By The Therapeutically Damaged Tumor Microenvironment

Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair

Regulatory cross-talk determines the cellular levels of 53BP1 protein, a critical factor in DNA repair